AI Article Synopsis
- CTEPH and CTED are rare conditions that can develop after venous thromboembolism, likely sharing the same underlying mechanisms.
- Both conditions may be effectively treated with procedures like pulmonary endarterectomy and balloon pulmonary angioplasty, as well as medications such as Riociguat and subcutaneous treprostinil.
- These treatments can lead to significant improvement or near-cure for affected patients.
Article Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary vascular disease (CTED) are rare manifestations of venous thromboembolism. Presumably, CTEPH and CTED are variants of the same pathophysiological mechanism. CTEPH and CTED can be near-cured by pulmonary endarterectomy, balloon pulmonary angioplasty, and medical treatment with Riociguat or subcutaneous treprostinil, which are the approved drugs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ccm.2020.11.014 | DOI Listing |
Publication Analysis
Top Keywords
chronic thromboembolic
16
thromboembolic pulmonary
12
pulmonary hypertension
8
cteph cted
8
pulmonary
5
chronic
4
thromboembolic disease
4
disease chronic
4
hypertension chronic
4
hypertension cteph
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!